Biodelivery Sciences International reported 100.71M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US $ 13.27M 13.06M
Adamas Pharmaceuticals ADMS:US 78.62M 10.17M
Agile Therapeutics AGRX:US $ 14.74M 11.38M
Alimera Sciences ALIM:US $ 21.52M 3.26M
Biocryst Pharmaceuticals BCRX:US $ 199.6M 10.72M
Biodelivery Sciences International BDSI:US 100.71M 19.14M
Cara Therapeutics CARA:US $ 22.99M 656K
Cti Biopharma CTIC:US $ 95.28M 23.4M
Daiichi Sankyo 4568:JP Y 550054M 197792M
Depomed DEPO:US $ 58.73M 4.3M
Endo International Ordinary Shares ENDP:US $ 1568.66M 23.49M
Jazz Pharmaceuticals JAZZ:US 1000 0
Knight Therapeutics Inc GUD:CN C$ 12.75M 10.46M
Lannett LCI:US $ 105.32M 12.04M
Mannkind MNKD:US $ 51.74M 10.78M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Pacira Pharmaceuticals PCRX:US $ 134.04M 28.26M
Redhill Biopharma RDHL:US $ 23.25M 28.56M
Revance Therapeutics RVNC:US $ 127.18M 40.46M
Teva Pharmaceutical TEVA:IT 2.04B 391M